ProfileGDS4132 / 223527_s_at
TitlePPAR-γ agonist pioglitazone effect on obese women with polycystic ovary syndrome: skeletal muscle
OrganismHomo sapiens


pretreatment pioglitazone GSM201542 GSM201543 GSM201544 GSM201545 GSM201829 GSM201830 GSM201831 GSM201832 GSM201833 GSM201834 GSM201835 GSM201836 GSM201837 GSM201838 GSM201839 GSM201840 GSM201841 GSM201842 GSM201843 GSM201844 40% 38% 45% 36% 40% 39% 39% 42% 36% 37% 36% 34% 42% 47% 41% 41% 51% 45% 43% 41% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM201542Muscle PCOS pioglitazone 101104.20940
GSM201543Muscle PCOS pioglitazone 12190.01138
GSM201544Muscle PCOS pioglitazone 161119.88145
GSM201545Muscle PCOS pioglitazone 20199.40136
GSM201829Muscle PCOS pioglitazone 231110.30240
GSM201830Muscle PCOS pioglitazon 251105.35639
GSM201831Muscle PCOS pioglitazone 27198.475439
GSM201832Muscle PCOS pioglitazone 31109.45142
GSM201833Muscle PCOS pioglitazone 4186.978336
GSM201834Muscle PCOS pioglitazone 8193.650237
GSM201835Muscle PCOS after pioglitazone 10277.914536
GSM201836Muscle PCOS after pioglitazone 12275.149434
GSM201837Muscle PCOS after pioglitazone 16292.90442
GSM201838Muscle PCOS after pioglitazone 202114.61147
GSM201839Muscle PCOS after pioglitazone 23297.294641
GSM201840Muscle PCOS after pioglitazone 252101.97341
GSM201841Muscle PCOS after pioglitazone 272122.4751
GSM201842Muscle PCOS after pioglitazone 3298.521345
GSM201843Muscle PCOS after pioglitazone 42108.07843
GSM201844Muscle PCOS after pioglitazone 82100.14541